跳至主要内容
临床试验/ACTRN12606000406505
ACTRN12606000406505已完成3 期

Clinical efficacy of Moxifloxacin in the treatment of Bacterial Keratitis: A Randomised Clinical Trial

Centre for Eye Research Australia0 个研究点目标入组 229 人开始时间: 2006年9月18日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
229

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
1 Years 至 ot stated(—)
性别
All

入选标准

  • Patients at least one year of age, of any race and either sex.•Have a diagnosis of bacterial keratitis based on clinical observation.•Must be able to understand and sign an informed consent form that has been approved by the Human Research and Ethics Committee. If the patient is under 18 years of age, the informed consent must be understood and signed by the patient’s legally authorized representative (parent or guardian).•Must agree to comply with the visit schedule and other requirements of the study. The parent or guardian must agree to ensure compliance of patients less than 18 years of age.•If patients have an infection in both eyes, then only one will be treated with the study medication.

排除标准

  • Known allergy to fluoroquinolones, aminoglycosides, penicillins, cephalosporins or benzalkonium chloride.•Pregnant females.•Patients under 1 year of age.•Suspected fungal, viral (e.g. Herpes simplex) or Acanthomoeba infection based on clinical observation.•Patients to be treated with subconjunctival injection(s) of antibiotic(s).

研究者

相似试验